4D Molecular Therapeutics (FDMT) Return on Sales (2020 - 2026)
4D Molecular Therapeutics (FDMT) reported Return on Sales of 0.23% for Q1 2026, up 3409.0% year-over-year from 0.01% in Q1 2025, and down 9987.58% quarter-over-quarter from 0.0% in Q4 2025.
4D Molecular Therapeutics (FDMT) Return on Sales (2020 - 2026) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 7 years of Return on Sales data on file, last reported at 0.23% in Q1 2026.
- Return on Sales for Q1 2026 came in at 0.23%, up 3409.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02% (up 7669.0% YoY), and the FY2025 annual result was 0.02%, up 4344.0% from the prior year.
- Return on Sales slipped to 0.23% in Q1 2026 per FDMT's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Sales peaked at 16.99% in Q4 2023 and troughed at 496.5% in Q4 2024.
- A 5-year average of 46.42% and a median of 1.24% in 2023 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2024 and 2025: Return on Sales sank 51349 bps in 2024, then soared 49650 bps in 2025.
- A 5-year view of Return on Sales shows it stood at 0.22% in 2022, then soared by 7835 bps to 16.99% in 2023, then plunged by 3023 bps to 496.5% in 2024, then soared by 100 bps to 0.0% in 2025, then tumbled by 9988 bps to 0.23% in 2026.
- Business Quant data shows FDMT's Return on Sales at 0.23% in Q1 2026, 0.0% in Q4 2025, and 6.32% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | 4D Molecular Therapeutics | 656.48 Mn | 656.48 Mn | - | -0.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.23% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -6.32% |
| Jun 30, 2025 | -36.40% |
| Mar 31, 2025 | -34.31% |
| Dec 31, 2024 | -496.50% |
| Sep 30, 2024 | -146.14% |
| Jun 30, 2024 | -69.82% |
| Mar 31, 2024 | -11.57% |
| Dec 31, 2023 | 16.99% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -1.24% |
| Mar 31, 2023 | -0.96% |
| Dec 31, 2022 | -0.22% |
| Sep 30, 2022 | -0.51% |
| Jun 30, 2022 | -1.73% |
| Mar 31, 2022 | -0.22% |
| Dec 31, 2021 | -2.73% |
| Sep 30, 2021 | -0.16% |
| Jun 30, 2021 | -0.01% |